News

The company, to be called Daiichi Sankyo Ilac Tikaret, will be headquartered in Istanbul and will initially focus on marketing the osteoporosis medication Evista (Raloxifen). The affiliate in

USGI’s incisionless surgery platform, the EndoSurgical Operating System (EOS), is designed to address a wide range of surgical indications. Surgeons and gastroenterologists currently use the EOS to perform

This is a continuance of the licensing partnership arGentis has with the Southern College of Optometry and becomes the third prospective therapy for dry eye syndrome (DES) that

Located at 2/F of Building A, Jinxiongda Technology Park, Guanlan, Bao’an District, Shenzhen, China, the new 18,000 square foot facility currently houses a staff of twenty-five employees. SunTech

The Company has initiated an executive search for this position and, on interim basis, Christopher Reinhard, the company’s executive chairman will assume executive responsibilities for the operations of

Merck plans to conduct a number of clinical studies in hypertensive patients involving single and multiple ascending dosing, prior to the selection of a compound to be advanced

Ricardo Diaz will head Chiltern’s new office as country manager. Mr Diaz has over 10 years experience in clinical research and holds a master’s degree in Pharmacology, a

The trial enrolled a total of 48 patients of which 37 have reached the final 12 month follow up evaluation. The data for these first 37 patients indicate

In preparation for conducting a thorough QT study (TQT), Repros has completed a pilot trial dosing healthy female volunteers for seven days with Proellex 200mg. Formal QT studies